|
|||||
|
|
Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer |
|
| Authors: | Christian Manegold Johan Vansteenkiste Felipe Cardenal Wolfgang Schuette Penella J. Woll Ernst Ulsperger Anne Kerber Josef Eckmayr Joachim von Pawel |
| Affiliation: | 1. Medizinische Fakult?t Mannheim der Universit?t Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany 10. Chirurgische Universit?tsklinik – Interdisziplin?re Thorakale Onkologie, Universit?tsmedizin, Medizinische Fakult?t Mannheim der Universit?t Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany 2. University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium 3. Institut Català d’Oncologia, Avgda Gran Via 199-203, 08907, L’Hospitalet, Barcelona, Spain 4. Krankenhaus Martha-Maria Halle-D?lau, Roentgenstra?e 1, 06120, Halle, Germany 5. University of Sheffield, Whitham Road, S10 2SJ, Sheffield, UK 6. KHR Hietzing, Wolkersbergenstra?e 1, 1130, Vienna, Austria 7. Merck KGaA, Frankfurter Stra?e 250, 64293, Darmstadt, Germany 8. Klinikum Kreuzschwestern Wels, Grieskirchner Stra?e 42, 4600, Wels, Austria 9. Asklepios Fachkliniken München-Gauting, Robert-Koch-Allee 2, 82131, Gauting, Germany |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |